Oak Associates’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-16,361
Closed -$1.53M 135
2022
Q1
$1.53M Hold
16,361
0.09% 91
2021
Q4
$1.39M Buy
+16,361
New +$1.39M 0.07% 99